Dark Streaming/Mobile Old Site Home Daily Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
10:30:37 EDT Tue 30 May 2023
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

News for C:INNO from 2022-05-31 to 2023-05-30 - 32 items News ReleasesIn The NewsOther CAUS
DateSymCompanyPriceTypeHeadline
2023-05-08 16:44C:INNOInnocan Pharma Corp0.23News ReleaseInnocan injects goat with liposomal-CBD in preclinical
2023-04-18 17:15C:INNOInnocan Pharma Corp0.25News ReleaseInnocan talks gross profit; NR omits 2022 net P&L
2023-04-03 13:25C:INNOInnocan Pharma Corp0.235News ReleaseInnocan Pharma applies for cannabinoid platform patent
2023-03-30 15:27C:INNOInnocan Pharma Corp0.24SEDAR Annual Information FormSEDAR Annual Information Form
2023-03-30 15:24C:INNOInnocan Pharma Corp0.24SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2023-03-30 15:24C:INNOInnocan Pharma Corp0.24SEDAR MD & ASEDAR MD & A
2023-03-23 09:22C:INNOInnocan Pharma Corp0.25News ReleaseInnocan releases results of vaginal derma efficacy test
2023-03-17 09:47C:INNOInnocan Pharma Corp0.24News ReleaseInnocan Pharma forms CBD veterinary group
2023-03-13 01:20C:INNOInnocan Pharma Corp0.25News ReleaseInnocan receives U.S. patent notice of allowance
2023-02-21 12:29C:INNOInnocan Pharma Corp0.29News ReleaseInnocan talks compassionate care trial on dog
2023-02-16 16:23C:INNOInnocan Pharma Corp0.285News ReleaseInnocan Pharma recaps 2022 operations
2022-12-02 16:14C:INNOInnocan Pharma Corp0.28News ReleaseInnocan hires Benitz Consulting for commercialization
2022-11-29 11:16C:INNOInnocan Pharma Corp0.27News ReleaseInnocan Pharma loses $2.7-million (U.S.) in Q3 2022
2022-11-29 02:22C:INNOInnocan Pharma Corp0.27SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2022-11-29 02:22C:INNOInnocan Pharma Corp0.27SEDAR MD & ASEDAR MD & A
2022-11-18 09:57C:INNOInnocan Pharma Corp0.29News ReleaseInnocan Pharma adds Topchishvili to advisory committee
2022-11-09 17:46C:INNOInnocan Pharma Corp0.30News ReleaseInnocan Pharma starts using Priority ERP software
2022-10-06 16:58C:INNOInnocan Pharma Corp0.31News ReleaseInnocan's psoriasis treatment patent app goes national
2022-09-21 11:54C:INNOInnocan Pharma Corp0.345News ReleaseInnocan patent application enters in U.S., EU
2022-09-09 09:21C:INNOInnocan Pharma Corp0.425News ReleaseInnocan talks epilepsy LPT preclinical trial on dog
2022-08-30 10:48C:INNOInnocan Pharma Corp0.47News ReleaseInnocan losses rise to $1.8-million (U.S.) in Q2 2022
2022-08-30 02:43C:INNOInnocan Pharma Corp0.47SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2022-08-30 02:43C:INNOInnocan Pharma Corp0.47SEDAR MD & ASEDAR MD & A
2022-08-17 09:47C:INNOInnocan Pharma Corp0.52News ReleaseInnocan's LPT study in dogs meets preclinical end point
2022-08-11 11:53C:INNOInnocan Pharma Corp0.48News ReleaseInnocan talks bioavailability in dog clinical study
2022-08-05 11:38C:INNOInnocan Pharma Corp0.475News ReleaseInnocan Pharma files patent for hair loss product
2022-07-29 10:24C:INNOInnocan Pharma Corp0.51News ReleaseInnocan applies for U.S. patent for diabetic symptoms
2022-07-12 11:35C:INNOInnocan Pharma Corp0.51News ReleaseInnocan appoints Vasilevski as analytical chemist
2022-07-06 16:44C:INNOInnocan Pharma Corp0.52News ReleaseInnocan releases preclinical dog epilepsy trial results
2022-06-24 16:13C:INNOInnocan Pharma Corp0.55News ReleaseInnocan completes preclinical trial for dog pain
2022-06-17 16:14C:INNOInnocan Pharma Corp0.54News ReleaseInnocan files patent for vaginal atrophy treatment
2022-06-10 16:12C:INNOInnocan Pharma Corp0.57News ReleaseInnocan Pharma talks LPT dog trial results